Patient perception of cervical screening among women living with human immuno-deficiency virus infection attending an antiretroviral therapy clinic in urban South Africa

Journal of Obstetrics and Gynaecology

Volumn 29, Issue 1, 2009, Pages 44-48

  Wake, R M ^a,b   Rebe, K ^a   Burch, V C ^a  

^a GF Jooste Hospital   (South Africa)

^b NONE   (United Kingdom)

Author keywords

Africa; cervical dysplasia; HIV; prevention; screening

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CANCER SCREENING; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; OPEN ENDED QUESTIONNAIRE; OUTPATIENT DEPARTMENT; PAPANICOLAOU TEST; PATIENT ATTITUDE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEMI STRUCTURED INTERVIEW; SOUTH AFRICA; UTERINE CERVIX CANCER;

ADULT; AMBULATORY CARE FACILITIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; RISK FACTORS; SOUTH AFRICA; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 65249154262     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610802484070     Document Type: Article

References (20)

1. Agosti JM, Goldie SJ. 2007. Introducing HPV vaccine in developing countries - key challenges and issues. New England Journal of Medicine 356:1908-1910.
2. Burch VC, Benatar SR. 2006. Rational planning of health care service based on observed need. South African Medical Journal 96:796-802.
3. Castro KG, Ward JW, Slutsker L, Buehler JW, Jaffe HW, Berkelman RL, et al. 1992. Revised Classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morbidity and Mortality Weekly Report 41 (RR-17):1-19. Centre for Disease Control. 2005. Table 1. Cervical Cancer Screening Guidelines. Available at http://www.cdc.gov/std/hpv/ ScreeningTables.pdf. Accessed on 23.04.07.
4. Chin KM, Sidhu JS, Janssen RS, Weber JT. 1998. Invasive cervical cancer in human immunodeficiency virus-infected and uninfected hospital patients. Obstetrics and Gynecology 92:83- 89.
5. Denny L, Quinn M, Sankaranarayanan R. 2006. Screening for cervical cancer in developing countries. Vaccine 24(Suppl 3): 71-77.
6. Department of Health. Republic of South Africa. 2006. National HIV and syphilis antenatal seroprevalence survey of women in South Africa 2004. Pretoria: DOH. Available at http://www.doh.gov.za/docs/index.html. Accessed on 24.06.06.
7. Ellerbrock TV, Chiasson M, Bush TJ, Sun X, Sawo D, Brudney K, et al. 2000. Incidence of Cervical Squamous Intraepithelial lesions in HIV-infected women. The Journal of the American Medical Association 283:1031-1037.
8. Franco EL. 2007. Commentary: health inequity could increase in poor countries if universal HPV vaccination is not adopted. British Medical Association 335:378-379.
9. Gallant JE. The HIV positive patient: initial Encounter. 2006. Available at http://www.medscape.com/viewprogram/660. Accessed on 02.11.06.
10. Goldie S, Weinstein M, Kuntz K, Freedberg K. 1999. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Annals of Internal Medicine 130:97-107.
11. Goldie S, Kuhn L, Denny L, Pollack A, Wright T. 2001. Policy analysis of cervical screening strategies in lowresource settings. clinical benefits and cost-effectiveness. The Journal of the American Medical Association 24:3107- 3117.
12. Moodley JR, Hoffman M, Carrara H, Allan BR, Cooper DD, Rosenberg L, et al. 2006. HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. British Medical Association Cancer 6:135.
13. Nappi L, Carreiro C, Bettochi S, Herrero J, Vimercati A, Putignano G. 2005. Cervical squamous intraepithelial lesions of lowgrade in HIV infected women: recurrence, persistence and progression in treated and untreated women. European Journal of Obstetrics, Gynecology, and Reproductive Biology 121:226- 232.
14. NHS Cancer Screening Programmes. 2004. Colposcopy and programme management. Guidelines for the NHS cervical screening programme. Sheffield: NHSCSP.
15. Palefsky JM, Gillison ML, Strickler HD. 2006. Chapter 16: HPV vaccines in immunocompromised women and men. Vaccine 24 (Suppl 3): S140-S146.
16. Parkin DM, Bray FI, Devesa SS. 2001. Cancer burden in the year 2000. The global picture. European Journal of Cancer 37(Suppl 1):S4-S66.
17. Pollack A, Balkin MS, Denny L. 2006. Cervical cancer: a call for political will. International Journal of Gynecology & Obstetrics 94:332-342.
18. Sankaranarayanan R, Madhukar Budukh A, Rajkumar R. 2001. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bulletin of the World Health Organization 79:954-962.
19. Simbayi LC, Strebel A, Andipatin M, Potgieter C, Ratele K, Shabalala N, et al. The evaluation of immediate behavioural outcomes of the syndromic case management approach for the treatment of patients with sexually transmitted infections at PHC centres in South Africa: knowledge, attitudes, beliefs and sexual behaviour. 2004. Sahara Journal 1:25-45.
20. Wilkinson D, Abdool Karim SS, Harrison A, Lurie M, Colvin M, Connolly C, et al. 1999. Unrecognized sexually transmitted infections in rural South African women: a hidden epidemic. Bulletin of the World Health Organization 77:22-28. World Health Organisation. 2005. Treat 3 million by 2005. Summary: country profiles for HIV/AIDS treatment scale-up. Geneva: WHO. World Health Organisation. 2006. Comprehensive cervical cancer control. A guide to essential practice. Geneva: WHO.